Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
01 1Ofichem BV
01 1Palmitoylethanolamide
01 1Netherlands
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
NDC Package Code : 62675-1309
Start Marketing Date : 2018-07-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Palmitoylethanolamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Palmitoylethanolamide, including repackagers and relabelers. The FDA regulates Palmitoylethanolamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Palmitoylethanolamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Palmitoylethanolamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Palmitoylethanolamide supplier is an individual or a company that provides Palmitoylethanolamide active pharmaceutical ingredient (API) or Palmitoylethanolamide finished formulations upon request. The Palmitoylethanolamide suppliers may include Palmitoylethanolamide API manufacturers, exporters, distributors and traders.
click here to find a list of Palmitoylethanolamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Palmitoylethanolamide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Palmitoylethanolamide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Palmitoylethanolamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Palmitoylethanolamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Palmitoylethanolamide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Palmitoylethanolamide suppliers with NDC on PharmaCompass.
We have 1 companies offering Palmitoylethanolamide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
